Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2014

Filed with the SEC on Mar 14, 2014 and accepted by EDGAR at Mar 14, 2014, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2013-11-01 to 2014-01-31$535.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2013-05-01 to 2014-01-31$1.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-11-01 to 2014-01-31−$1.4mus-gaap:OperatingIncomeLoss
Operating income9 months2013-05-01 to 2014-01-31−$3.9mus-gaap:OperatingIncomeLoss
Income tax3 months2013-11-01 to 2014-01-31$5.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2013-05-01 to 2014-01-31$13.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-11-01 to 2014-01-31−$574.0kus-gaap:NetIncomeLoss
Net income9 months2013-05-01 to 2014-01-31−$5.1mus-gaap:NetIncomeLoss
Operating cash flow9 months2013-05-01 to 2014-01-31−$3.6mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2013-05-01 to 2014-01-31$164.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2014-01-31$5.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-01-31$9.2mus-gaap:AssetsCurrent
Total assetsAt period end2014-01-31$10.5mus-gaap:Assets
Current liabilitiesAt period end2014-01-31$3.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-01-31$6.0mus-gaap:Liabilities
Shareholders' equityAt period end2014-01-31$4.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-14-015818. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.